Bone marrow as a target organ of systemic lupus erythematosus: analysis of cases with myelofibrosis.
Döndü Üsküdar CansuHava Üsküdar TekeSerap IşiksoyCengiz KorkmazPublished in: International journal of rheumatic diseases (2018)
MF is common in SLE patients. SLE-associated MF as an additional factor for cytopenia in SLE patients may lead to delayed response to appropriate therapy, which may be dependent on the increased grade of BM fibrosis.